Respiratory Syncytial Virus: From Primary Care to Critical Care

Journal of Pediatric Health Care

Volumn 23, Issue 2, 2009, Pages 101-108

  Sorce, Lauren R ^a  

^a NONE

Author keywords

bronchiolitis; etiology; RSV; RSV prophylaxis; RSV therapy

Indexed keywords

ARTICLE; CHILD; HUMAN; INFANT; INTENSIVE CARE; PRIMARY HEALTH CARE; VIRUS INFECTION;

CHILD; CRITICAL CARE; HUMANS; INFANT; PRIMARY HEALTH CARE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 60349122621     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2007.11.004     Document Type: Article

References (52)

1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IVIG. Pediatrics 102 (1998) 1211-1216
2. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 (2003) 1442-1446
3. Antonow J.A., Hansen K., McKinstry C.A., and Byington C.L. Sepsis evaluations in hospitalized infants with bronchiolitis. [Electronic version]. The Pediatric Infectious Disease Journal 17 (1998) 231-236
4. Bloomfield P., Dalton D., Karleka A., Kesson A., Duncan G., and Isaacs D. Bacteremia and antibiotic use in respiratory syncytial virus infections. [Electronic version]. Archives of Disease in Childhood 49 (2004) 363-367
5. Castro-Rodriguez J.A., Holberg C.J., Morgan W.J., Wright A.L., Halonen M., Taussig L.M., et al. Relation of two different subtypes of croup before age three to wheezing, atopy and pulmonary function during childhood: A prospective study. [Electronic version]. Pediatrics 107 (2001) 512-518
6. Chanock R.M., Roizman B., and Meyers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent. Part I: Isolation, properties and characterization. American Journal of Hygiene 66 (1957) 281-290
7. Checchia P.A., Appel H.J., Kahn S., Smith F.A., Shulman S.T., Pahl E., et al. Myocardial injury in children with respiratory syncytial virus infection. [Electronic version]. Pediatric Critical Care Medicine 1 (2000) 146-150
8. Davison C., Ventre K.M., Luchetti M., and Randolph A.G. Efficacy of interventions for bronchiolitis in critically ill infants: A systematic review and meta analysis. Pediatric Critical Care Medicine 5 (2004) 482-489
9. DeVincenzo J.P., El Saleeby C.M., and Bush A.J. Respiratory syncytial virus load predicts disease severity in previously healthy infants. [Electronic version]. Journal of Infectious Diseases 191 (2005) 1861-1868
10. Duttweiler L., Nadal D., and Frey B. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. [Electronic version]. Archives of Disease in Childhood 89 (2004) 1155-1157
11. Eisenhut M., Sidaras D., Johnson R., Newland P., and Thorburn K. Cardiac troponin T levels and myocardial involvement in children with severe respiratory syncytial virus lung disease. Acta Paediatrica 83 (2004) 887-890
12. Feltes T.F., Cabalka A.K., Meissner H.C., Piazza F.M., Carlin D.A., Top F.H., et al., Cardiac Synagis Study Group. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. Journal of Pediatrics 143 (2003) 532-540
13. Figueras-Aloy J., Carbonell-Estrany X., Quero J., and IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestation age of 33-35 weeks in Spain. The Pediatric Infectious Disease Journal 23 (2004) 815-820
14. Gilca R., Serres G.D., Tremblay M., Vachon M.L., Leblanc E., Bergeron M.G., et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. Journal of Infectious Diseases 293 (2006) 54-58
15. Goldrick R.A. Respiratory syncytial virus. American Journal of Nursing 104 (2004) 54-56
16. Henrickson K.J. Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatric Annals 34 (2005) 24-31
17. Holman R.C., Shay D.K., Curns A.T., Lingappa J.R., and Anderson L.J. Risk factors for bronchiolitis-associated deaths among infant in the United States. The Pediatric Infectious Disease Journal 22 (2003) 483-489
18. Howard T.S., Hoffman L.H., Stang P.E., and Simoes E.A.F. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges and mortality. [Electronic version]. The Journal of Pediatrics 137 (2000) 227-232
19. IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. [Electronic version]. Pediatrics 102 (1998) 531-537
20. Jafri H.S., Chavez-Bueno S., Mejias A., Gomez A.M., Rios A.M., Nassi S.S., et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. [Electronic version]. Journal of Infectious Diseases 189 (2004) 1856-1865
21. Kellner J.D., Ohlsson A., Gadomski A.M., and Wang E.E.L. Bronchodilators for bronchiolitis. [Electronic version]. The Cochrane Database of Systematic Reviews; 2 (2006)
22. Kim H.W., Canchola J.G., Brandt B.D., Pyles G., Chanock R.M., Jensen K., et al. Respiratory syncytial virus in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89 (1969) 422-434
23. King V.J., Viswanathan M., Bordley C., Jackman A.M., Sutton S.F., Lohr K.N., et al. Pharmacologic treatment of bronchiolitis in infants and children a systematic review. [Electronic version]. Archives of Pediatric and Adolescent Medicine 158 (2004) 127-137
24. Kneyber M.C.J., van Oud-Alblas H.B., van Vliet M., Uiterwaal C.S.P.M., Kimpen J.L.L., and van Vught A.J. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory track disease. [Electronic version]. Intensive Care Medicine 31 (2005) 680-685
25. Law B.J., Langley J.M., Allen U., Paes B., Lee D.S.C., Mitchell I., et al. The pediatric investigators collaborative network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. The Pediatric Infectious Disease Journal 23 (2004) 806-814
26. LeSaux N., Gaboury I., and MacDonald N. Maternal respiratory syncytial virus antibody titers: season and children matter. The Pediatric Infectious Disease Journal 22 (2003) 563-564
27. Levine D.A., Platt S.K., Dayan P.S., Macias C.G., Zorc J.J., Krief W., et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. [Electronic version]. Pediatrics 116 (2004) 1728-1734
28. Mandelberg A., Tal G., Witzling M., Someck E., Houri S., Balin A., et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with vial bronchiolitis. [Electronic version]. Chest 123 (2003) 481-487
29. Martinello R.A., Chen M.D., Weibel C., and Kahn J.S. Correlation between respiratory syncytial virus genotype and severity of illness. The Journal of Infectious Diseases 186 (2002) 839-842
30. Mejais A., Chavez-Bueno S., Rios A.M., Aten M.F., Raynor B., Peromingo E., et al. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrobial Agents and Chemotherapy 49 (2005) 4700-4707
31. Meissner H.C. Selected populations at increased risk from respiratory syncytial virus infection. [Electronic version]. The Pediatric Infectious Disease Journal 22 (2003) S40-S45
32. Moynihan J.A., Brown L., Sehra R., and Checcia P.A. Cardiac troponin I as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: A pilot study. [Electronic version]. The American Journal of Emergency Medicine 21 (2003) 479-482
33. Moynihan J.A., Kim T.Y., Young T., and Checchia P.A. Rate of palivizumab administration in accordance with current recommendations among hospitalized children. Journal of Pediatric Heath Care 18 (2004) 224-227
34. Openshaw P.J.M. Potential therapeutic implications of new insights into respiratory syncytial virus disease. [Electronic version]. Respiratory Research 3 (2002) S15-S20
35. Oray-Schrom P., Phoenix C., St. Martin D., and Amoateng-Adjepong Y. Sepsis workup in febrile infants 0-90 days of age with respiratory syncytial virus infection. [Electronic version]. Pediatric Emergency Care 195 (2003) 314-319
36. Panitch H.B. Viral respiratory infection in children with technology dependence and neuromuscular disorders. [Electronic version]. The Pediatric Infectious Disease Journal 23 (2004) S222-S227
37. Prais D., Schonfeld T., and Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. [Electronic version]. Pediatrics 112 (2003) 548-552
38. Purcell K., and Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. [Electronic version]. The Pediatric Infectious Disease Journal 23 (2004) 267-269
39. Ramadan H.H., Farr R.W., and Wetmore S.J. Adenovirus and respiratory syncytial virus in chronic sinusitis using polymerase chain reaction. [Electronic version]. Laryngoscope 107 (1997) 923-925
40. Randolph A.G., Reder L., and Englund J.A. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. [Electronic version]. The Pediatric Infectious Disease Journal 23 (2004) 990-994
41. Roush, D. (2007). Respiratory syncytial virus (RSV). Retrieved February 13, 2008, from http://www.nlm.nih.gov/medlineplus/ency/article/001564.htm
42. Sarrell E.M., Tal G., Witzling M., Someck E., Houri S., Cohen H.A., et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. [Electronic version]. Chest 233 (2002) 2015-2020
43. Sato M., Saito R., Takatsugu S., Sano Y., Nishikawa M., Sasaki A., et al. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. Journal of Clinical Microbiology 43 (2005) 36-40
44. Sheeran P., Hasan J., Carubelli C., Saavedra J., Johnson C., Krisher K., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. [Electronic version]. The Pediatric Infectious Disease Journal 18 (1999) 115-122
45. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. American Journal of Respiratory and Critical Care Medicine 171 (2005) 137-141
46. Simoes E.A. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. The Journal of Pediatrics 143 5 Suppl. (2003) S118-S126
47. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. [Electronic version]. Lancet 254 (1999) 541-545
48. Stensballe L.G., Kristensen K., Simoes E.A.F., Jensen H., Nielsen J., Benn C.S., et al. Atopic disposition, wheezing and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: A nested case-control study. [Electronic version]. Pediatrics 118 (2006) 1360-1368
49. Tristram D.A., and Welliver R.C. Respiratory syncytial virus. [Electronic version]. In: Long S.S., Pickering L.K., and Probe C.G. (Eds). Long: Principles and practice of pediatric infectious diseases. 2nd ed. (2003), Elsevier, New York 1140-1149
50. Venkatesh M.P., and Weisman L.E. Prevention and treatment of respiratory syncytial virus infection in infants: An update. Expert Review of Vaccines 5 (2006) 261-268
51. Welliver R.C. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. The Journal of Pediatrics 143 5 Suppl. (2003) S112-S117
52. Zlateva K.T., and Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial viral pneumonia. The Pediatric Infectious Disease Journal 23 (2004) 1065-1066